These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9123594)

  • 21. Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18.
    Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
    Transplant Proc; 1994 Jun; 26(3):1251. PubMed ID: 7913260
    [No Abstract]   [Full Text] [Related]  

  • 22. Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.
    Urbani L; Cardoso J; Soubrane O; Houssin D; Gautreau C
    Transplant Proc; 2000 Dec; 32(8):2707-9. PubMed ID: 11134770
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of various routes of donor-specific antigen administration on graft survival in a model of discordant heart xenotransplantation.
    Akpinar E; Arikan U; Bilgin N
    Transplant Proc; 1998 May; 30(3):809-11. PubMed ID: 9595108
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.
    Xia W; Fearon DT; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):410-1. PubMed ID: 8438357
    [No Abstract]   [Full Text] [Related]  

  • 25. Complement depletion prolongs discordant cardiac xenograft survival in rodents and non-human primates.
    Leventhal JR; Dalmasso AP; Cromwell JW; Manivel CJ; Bolman RM; Matas AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):398-9. PubMed ID: 8438352
    [No Abstract]   [Full Text] [Related]  

  • 26. Apyrase administration prolongs discordant xenograft survival.
    Koyamada N; Miyatake T; Candinas D; Hechenleitner P; Siegel J; Hancock WW; Bach FH; Robson SC
    Transplantation; 1996 Dec; 62(12):1739-43. PubMed ID: 8990354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor pretreatment prolongs survival of discordant xenografts.
    Jefferson KP; Tyerman KS; McLeish M; Collier DS; Thiru S
    Transplant Proc; 1991 Aug; 23(4):2280-1. PubMed ID: 1871871
    [No Abstract]   [Full Text] [Related]  

  • 28. Three-month survival of HDAFF transgenic pig hearts transplanted into primates.
    Bhatti FN; Schmoeckel M; Zaidi A; Cozzi E; Chavez G; Goddard M; Dunning JJ; Wallwork J; White DJ
    Transplant Proc; 1999; 31(1-2):958. PubMed ID: 10083425
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
    Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW
    Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
    Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts.
    Pruitt Sk; Bollinger RR; Collins BH; Marsh HC; Levin JL; Rudolph AR; Baldwin WM; Sanfilippo F
    Transplant Proc; 1996 Apr; 28(2):756. PubMed ID: 8623382
    [No Abstract]   [Full Text] [Related]  

  • 32. Donor graft perfusion pre-transplant prolongs xenograft survival.
    Henry ML; Bendle MD
    Transplant Proc; 1996 Apr; 28(2):595. PubMed ID: 8623291
    [No Abstract]   [Full Text] [Related]  

  • 33. White blood cells and platelets are integral to the hyperacute rejection of the pig heart by human blood.
    Young VK; Kaspar-König W; Tew DN; Wallwork J; White DJ; Pierson RN
    Transplant Proc; 1995 Feb; 27(1):272-3. PubMed ID: 7879000
    [No Abstract]   [Full Text] [Related]  

  • 34. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
    Candinas D; Bach FH; Hancock WW
    Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporine induces long-term xenograft survival in the mouse-to-C6-deficient rat heart transplantation model.
    Wu GS; Korsgren O; Tibell A
    Transplant Proc; 2000 Aug; 32(5):1015. PubMed ID: 10936325
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperacute xenograft rejection in the guinea pig to rat heart transplantation model.
    Bouwman E; Loonen EM; Wolvekamp M; de Bruin RW; Jeekel J; Marquet RL
    Transplant Proc; 1990 Jun; 22(3):1063-4. PubMed ID: 2349662
    [No Abstract]   [Full Text] [Related]  

  • 37. Phylogenetic disparity does not always equate with hyperacute rejection in xenotransplantation.
    Braidley PC; Dunning JJ; Wallwork J; White DJ
    Transplant Proc; 1994 Jun; 26(3):1230-1. PubMed ID: 8029897
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection.
    Pruitt SK; Baldwin WM; Marsh HC; Lin SS; Yeh CG; Bollinger RR
    Transplant Proc; 1992 Apr; 24(2):477-8. PubMed ID: 1566394
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic heart transplantation following xenogeneic bridging.
    Schütz A; Pratschke J; Breuer M; Hammer C; Engelhardt M; Brandl U; Babic R; Reichart B; Kemkes BM
    Transpl Int; 1992; 5 Suppl 1():S307-10. PubMed ID: 14621808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.